SOL S.p.A.

Milan Stock Exchange:SOL.MI

Sector

🏥 Health Care

Industries

💻 Telehealth

🧬 Biotechnology

💨 Gas

🏥 Hospitals & Clinics

🩺 Medical Instruments

Location

Italy

Market Cap

USD 4.92 B

Share Price

USD 54.25

Avg Daily Volume

40,276

Change (1 day)

-0.82%

Change (1 year)

58.57%

Change (YTD)

40.33%

SOL S.p.A. EBITDA for the year ending December 31, 2024: USD 404.96 M

SOL S.p.A. EBITDA is USD 404.96 M for the year ending December 31, 2024, a -1.51% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

SOL S.p.A. EBITDA for the year ending December 31, 2023 was USD 411.16 M, a 20.45% change year over year.
SOL S.p.A. EBITDA for the year ending December 31, 2022 was USD 341.35 M, a 17.40% change year over year.
SOL S.p.A. EBITDA for the year ending December 31, 2021 was USD 290.75 M, a -5.10% change year over year.
SOL S.p.A. EBITDA for the year ending December 31, 2020 was USD 306.39 M, a 39.65% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Milan Stock Exchange: SOL.MI

SOL S.p.A.

CEO	Engineer Aldo Fumagalli Romario
IPO Date	July 17, 1998
Location	Italy
Headquarters	Via Borgazzi, 27
Employees	7,200
Sector	🏥 Health Care
Industries Telehealth 🧬 Biotechnology 💨 Gas 🏥 Hospitals & Clinics 🩺 Medical Instruments

Description

SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases; and in home medical assistance and related medical equipment in Italy and internationally. The company offers technical and medical gases, including oxygen, nitrogen, argon, hydrogen, carbon and sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, and gaseous and liquid helium; gas for electronics; and ammonia and combustible gases for industrial use. It also provides home oxygen therapy, home mechanical ventilation, and aerosol therapy services, as well as the diagnosis and treatment of respiratory sleep disorders; services for artificial nutrition, insulin therapy with pumps, and immunotherapy, as well as services for the treatment of pain and Parkinson's disease; home healthcare and social care services; telemedicine and digital services; and healthcare aids. In addition, it provides medical devices; training services; InfoHealth SOLution, a web platform that allows to control plans, coordinate, and manage the activities; electromedical equipment services; hospital hygiene and environmental monitoring services; and ambulance management services. Further, it designs, constructs, and manages bio banks; distribution of medical and technical gases; produces and sells hydroelectric power; offers pre-and post-natal diagnostic screening services; produces and sells diagnostic systems; researches, develops, and markets products for research, diagnosis and clinical application in the hospital, environmental, veterinary and food sectors; and bioshipping services, as well as provides transfer, storage, and handling services of biological samples. Its products are used in the chemical, electronics, steel, metal, and food industries, as well as in environmental protection, and research and healthcare sectors. The company was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. is a subsidiary of Gas and Technologies World BV.